Torrent Recalls 104 More Lots of Tainted Losartan Tablets Torrent Recalls 104 More Lots of Tainted Losartan Tablets
The blood pressure tablets contain unacceptable levels of a potential carcinogen nitrosamine impurity that has prompted recalls by the company and other globally.News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 19, 2019 Category: Cardiology Tags: Cardiology News Alert Source Type: news
Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USP
Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited.
The Recall is expanded to include an additional 36 lots of Losartan potassium Tablets USP and 68 lots of Losartan Potassium/Hydrochlorothiazide Tablets, USP (Source: Food and Drug Administration)
Source: Food and Drug Administration - April 18, 2019 Category: Food Science Source Type: news
Defibrillator Hacking; Losartan Stay of Sentence; Guideline Evidence
(MedPage Today) -- Recent developments of interest in cardiovascular medicine (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - March 25, 2019 Category: Urology & Nephrology Source Type: news
Class 2 Medicines recall: Accord Healthcare Limited — Losartan potassium 50mg and 100mg film-coated tablets
Accord Healthcare Limited is recalling some batches of losartan potassium 50mg and 100mg film-coated tablets. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 22, 2019 Category: Drugs & Pharmacology Source Type: news
FDA eases standards to avoid blood pressure drug shortages
The FDA announced that it will temporarily allow certain manufacturers to continue distributing losartan containing impurities slightly above the interim acceptable intake limit, in order to avoid shortages of certain blood pressure drugs. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - March 22, 2019 Category: Pharmaceuticals Source Type: news
Three more batches of blood pressure drugs are recalled by UK officials
UK Government agency the Medicines and Healthcare products Regulatory Agency today issued a warning about losartan pills made by the company Accord. (Source: the Mail online | Health)
Source: the Mail online | Health - March 21, 2019 Category: Consumer Health News Source Type: news
FDA Permits Temporary Distribution of Tainted Losartan FDA Permits Temporary Distribution of Tainted Losartan
To ensure patient access, certain losartan manufacturers can temporarily distribute the medication with higher levels of the probable carcinogen, the agency said.News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 21, 2019 Category: Cardiology Tags: Cardiology News Alert Source Type: news
Morning Break: Safe-Enough Losartan;'Dirty' Kale; Governor's Pox Party
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 21, 2019 Category: American Health Source Type: news
Ripple Effect: Repackaged Losartan Recalled Due to Impurity Ripple Effect: Repackaged Losartan Recalled Due to Impurity
Legacy Pharmaceutical recalls 43 repackaged lots of losartan because of the presence of the probable carcinogen N-nitroso-N-methyl-4-aminobutyric acid (NMBA) in the active pharmaceutical ingredient.News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 18, 2019 Category: Cardiology Tags: Cardiology News Alert Source Type: news
More blood pressure drugs recalled over potential cancer risk
Another 43 lots of the blood pressure and heart failure drug Losartan have been recalled over the detection of a possible carcinogen in the tablets. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 17, 2019 Category: Consumer Health News Source Type: news
